title: Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease.
abstract: OBJECTIVE
  Rheumatoid arthritis (RA) has been reported to be associated with bone loss during the first years of the disease. The magnitude of this problem after the initial years has not yet been evaluated. In the present study, the change in bone mineral density (BMD) in patients with recent-onset RA as well as the effects of inflammation, mobility, and the use of prednisone on this change were studied in the first decade of the disease.
  
  
  METHODS
  BMD was measured twice in 76 RA patients with mean disease durations of 2.35 years at the first BMD measurement and 8.90 years at the second BMD measurement. BMD was measured in both hips using dual x-ray absorptiometry. Results were expressed as mean +/- SEM Z scores (using age- and sex-matched reference values) and as mean +/- SEM percent change in BMD (in gm/cm2) per year. The effects of inflammation, mobility, and the use of prednisone on change in BMD were evaluated using multiple linear regression analyses.
  
  
  RESULTS
  At the first BMD measurement, RA patients had lower BMD compared with the reference values (Z score -0.42+/-0.11, 95% confidence interval [95% CI] -0.64, -0.20). Between the 2 measurements, we observed a small decrease in BMD of -0.28+/-0.11%/year (95% CI -0.07 to -0.49). However, the rate of bone loss was smaller than expected. The Z score increased by 0.13+/-0.05 between the 2 BMD measurements (95% CI 0.02, 0.23). Only the use of prednisone was significantly associated with increased bone loss. In a separate analysis that included only postmenopausal women, increased physical activity and longer time since menopause were both associated with decreased bone loss. In this subgroup of patients, the use of prednisone was significantly associated with increased bone loss as well. A high erythrocyte sedimentation rate was associated with increased bone loss, but this did not reach statistical significance.
  
  
  CONCLUSIONS
  After the initial years of the disease, bone loss in RA patients is lower than expected compared with age- and sex-matched reference values. Postmenopausal RA patients with low levels of physical activity are at increased risk of losing bone. Use of prednisone was the only variable consistently associated with reduction in BMD in RA patients.
authors.affiliation: University of Medical Center Nijmegen, The Netherlands.
authors.forename: E J
authors.initials: EJ
authors.lastname: Kroot
authors.forename: M G
authors.initials: MG
authors.lastname: Nieuwenhuizen
authors.forename: M C
authors.initials: MC
authors.lastname: de Waal Malefijt
authors.forename: P L
authors.initials: PL
authors.lastname: van Riel
authors.forename: P C
authors.initials: PC
authors.lastname: Pasker-de Jong
authors.forename: R F
authors.initials: RF
authors.lastname: Laan
mesh_terms: D015502:Absorptiometry, Photon; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D015519:Bone Density; D004185:Disability Evaluation; D005260:Female; D006304:Health Status; D006615:Hip / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism*; D011241:Prednisone / Q000009:adverse effects; D011446:Prospective Studies; D012016:Reference Values; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires
chemical_list: D000893:Anti-Inflammatory Agents; D011241:Prednisone